Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)
China flag China · Delayed Price · Currency is CNY
8.78
+0.04 (0.46%)
Nov 21, 2024, 9:42 AM CST

Tonghua Dongbao Pharmaceutical Statistics

Total Valuation

Tonghua Dongbao Pharmaceutical has a market cap or net worth of CNY 16.94 billion. The enterprise value is 17.06 billion.

Market Cap 16.94B
Enterprise Value 17.06B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date Oct 25, 2024
Ex-Dividend Date n/a

Share Statistics

Tonghua Dongbao Pharmaceutical has 1.95 billion shares outstanding. The number of shares has increased by 6.93% in one year.

Current Share Class n/a
Shares Outstanding 1.95B
Shares Change (YoY) +6.93%
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.15%
Owned by Institutions (%) 11.59%
Float 1.14B

Valuation Ratios

The trailing PE ratio is 54.45 and the forward PE ratio is 23.17. Tonghua Dongbao Pharmaceutical's PEG ratio is 2.11.

PE Ratio 54.45
Forward PE 23.17
PS Ratio 7.64
PB Ratio 2.64
P/TBV Ratio n/a
P/FCF Ratio 227.34
P/OCF Ratio n/a
PEG Ratio 2.11
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.21, with an EV/FCF ratio of 229.01.

EV / Earnings 50.00
EV / Sales 7.02
EV / EBITDA 22.21
EV / EBIT 30.57
EV / FCF 229.01

Financial Position

The company has a current ratio of 4.30, with a Debt / Equity ratio of 0.08.

Current Ratio 4.30
Quick Ratio 2.32
Debt / Equity 0.08
Debt / EBITDA 0.64
Debt / FCF 6.61
Interest Coverage 40.00

Financial Efficiency

Return on equity (ROE) is 5.14% and return on invested capital (ROIC) is 5.02%.

Return on Equity (ROE) 5.14%
Return on Assets (ROA) 4.87%
Return on Capital (ROIC) 5.02%
Revenue Per Employee 760,839
Profits Per Employee 106,792
Employee Count 3,196
Asset Turnover 0.34
Inventory Turnover 0.74

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.85% in the last 52 weeks. The beta is 0.25, so Tonghua Dongbao Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y) 0.25
52-Week Price Change -27.85%
50-Day Moving Average 8.09
200-Day Moving Average 8.96
Relative Strength Index (RSI) 57.16
Average Volume (20 Days) 29,523,147

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Tonghua Dongbao Pharmaceutical had revenue of CNY 2.43 billion and earned 341.31 million in profits. Earnings per share was 0.16.

Revenue 2.43B
Gross Profit 1.88B
Operating Income 558.16M
Pretax Income 372.20M
Net Income 341.31M
EBITDA 768.43M
EBIT 558.16M
Earnings Per Share (EPS) 0.16
Full Income Statement

Balance Sheet

The company has 372.83 million in cash and 492.75 million in debt, giving a net cash position of -119.92 million or -0.06 per share.

Cash & Cash Equivalents 372.83M
Total Debt 492.75M
Net Cash -119.92M
Net Cash Per Share -0.06
Equity (Book Value) 6.43B
Book Value Per Share 3.30
Working Capital 1.50B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 613.51 million and capital expenditures -538.99 million, giving a free cash flow of 74.51 million.

Operating Cash Flow 613.51M
Capital Expenditures -538.99M
Free Cash Flow 74.51M
FCF Per Share 0.04
Full Cash Flow Statement

Margins

Gross margin is 77.49%, with operating and profit margins of 22.95% and 14.04%.

Gross Margin 77.49%
Operating Margin 22.95%
Pretax Margin 15.31%
Profit Margin 14.04%
EBITDA Margin 31.60%
EBIT Margin 22.95%
FCF Margin 3.06%

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 2.86%.

Dividend Per Share 0.25
Dividend Yield 2.86%
Dividend Growth (YoY) -50.00%
Years of Dividend Growth n/a
Payout Ratio 147.41%
Buyback Yield -6.93%
Shareholder Yield -4.07%
Earnings Yield 1.84%
FCF Yield 0.44%
Dividend Details

Stock Splits

The last stock split was on May 25, 2018. It was a forward split with a ratio of 1.2.

Last Split Date May 25, 2018
Split Type Forward
Split Ratio 1.2

Scores

Tonghua Dongbao Pharmaceutical has an Altman Z-Score of 18.28.

Altman Z-Score 18.28
Piotroski F-Score n/a